It is likely that both in RA and JRA two macrophage/fibroblast derived cytokines (TNF-alpha and IL-1) are major contributors to the induction of the chronic inflammatory state and to the development of severe tissue destruction. This study will be focused on one of them; TNF-alpha. To demonstrate that increased levels of TNF-alpha expression in synovium may be an important determinant of joint damage in JRA, we propose: 1) to estimate levels of TNF-alpha activity and TNF receptor expression in inflamed synovium, 2) to define cell sources and tissue distribution of TNF secretion as well as its potential cell targets and 3) to determine clinical correlates of TNF-alpha expression. Given the very small volume of synovial fluid obtainable in this pediatric population, semiquantitative PCR methodology was chosen as the best initial approach. In preliminary studies, elevated levels of TNF- alpha transcripts were demonstrated in a majority of JRA patients, and TNF-alpha appeared to be the most abundant cytokine of those tested. Immunoassays will be used to confirm that elevated levels of TNF-alpha transcripts in synovial fluid reflect increased amounts of cytokine protein. Next, a combination of in situ hybridization and immunohistochemistry will be used to detect cells secreting TNF-alpha as well as cells expressing TNF receptors. Identification of cell types expressing TNF receptors and, therefore, capable of responding to TNF- alpha will also identify the main mechanisms through which pathogenic effects of the TNF are carried out in JRA synovium. Further confirmation of major role of TNF-alpha in development of joint destruction could come from the demonstration of positive correlations between levels of TNF-alpha and/or its receptors in synovium and some clinical features of the disease reflecting the degree of joint damage. In the long term, these studies will lead to understanding of the relative contributions of components of the immune system to the disease as well as identifying the optimal targets for therapeutic intervention.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Thornton, Sherry; Sowders, Dawn; Aronow, Bruce et al. (2002) DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 105:155-68
Scola, Michael P; Thompson, Susan D; Brunner, Hermine I et al. (2002) Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J Rheumatol 29:369-78
Thornton, S; Kuhn, K A; Finkelman, F D et al. (2001) NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2. Eur J Immunol 31:3355-60
Griffin, T A; Slack, J P; McCluskey, T S et al. (2000) Identification of proteassemblin, a mammalian homologue of the yeast protein, Ump1p, that is required for normal proteasome assembly. Mol Cell Biol Res Commun 3:212-7
Thornton, S; Boivin, G P; Kim, K N et al. (2000) Heterogeneous effects of IL-2 on collagen-induced arthritis. J Immunol 165:1557-63
Lovell, D J; Giannini, E H; Reiff, A et al. (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763-9
Hashkes, P J; Balistreri, W F; Bove, K E et al. (1999) The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 134:47-52
Lovell, D J; Lindsley, C B; Rennebohm, R M et al. (1999) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis D Arthritis Rheum 42:2213-9
Murray, K J; Grom, A A; Thompson, S D et al. (1998) Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol 25:1388-98
Sleight, B J; Prasad, V S; DeLaat, C et al. (1998) Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 22:375-80

Showing the most recent 10 out of 32 publications